D-0066-2025 Class II Terminated
FDA drug recall D-0066-2025 was initiated by Unexo Life Sciences Private Limited on October 24, 2024 and is designated Class II. Reason for recall: cGMP Deviations The recall status is terminated (terminated September 16, 2025). Affected quantity: 279,936 patches.
Recall Details
- Product Type
- Drugs
- Report Date
- December 4, 2024
- Initiation Date
- October 24, 2024
- Termination Date
- September 16, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 279,936 patches
Product Description
THERACARE Cold Hot Medicated Patch, Menthol 5%, 5 patches per box, Manufactured for: Veridian Healthcare, LLC, Gurnee, IL 60031 NDC 71101-954-05, UPC 8 45717 00818 1
Reason for Recall
cGMP Deviations
Distribution Pattern
Nationwide in the US
Code Information
UPC 8 45717 00818 1